Asian Journal Of Social Pharmacy

Abstract: Objective To study the influence of national drug centralized procurement policy on pharmaceutical enterprises manufacturing generic drugs and original drugs, so as to provide a reference for them to make different strategic choices. Methods Through the literature research on the related policies and the bidding data, the national drug centralized policies were studied systematically. Combined with the bid-winning price and price reduction range of the winning enterprises in the three rounds of centralized procurement, their difficulties, strategic choices and the winning factors were investigated. Besides, a model was established to clarify the optimal price of enterprises in the process of drug procurement. Results and Conclusion The strategic choices of enterprises in participating national drug centralized procurement are influenced by many factors such as the market share of the original varieties, active pharmaceutical ingredients (APIs) and cost. Therefore, corresponding strategies should be formulated according to the characteristics and interests of enterprises.

Key words: drug centralized procurement, pharmaceutical enterprises, game, strategy